FATE OF NITECAPONE, A NEW CATECHOL-O-METHYLTRANSFERASE INHIBITOR IN MAN - A STUDY WITH DOUBLE ISOTOPE TECHNIQUE

被引：0
|
作者：
PENTIKAINEN, PJ
SARAHEIMO, M
VUORELA, A
OTTOILA, P
KULTALAHTI, ER
WIKBERG, T
机构：
[1] UNIV HELSINKI,DEPT MED 3,SF-00100 HELSINKI 10,FINLAND
[2] ORION PHAMACEUT CO,RES CTR,ESPOO,FINLAND
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1990年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [1] The equine metabolism of the catechol-O-methyltransferase enzyme inhibitor nitecapone
    Stanley, Shawn
    Deng, Derek
    Van den Berg, Koos
    Foo, Hsiao Ching
    DRUG TESTING AND ANALYSIS, 2022, 14 (05) : 929 - 935
  • [2] Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man -: A study using a stable isotope technique
    Heikkinen, H
    Saraheimo, M
    Antila, S
    Ottoila, P
    Pentikäinen, PJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (11) : 821 - 826
  • [3] IDENTIFICATION OF MAJOR METABOLITES OF THE CATECHOL-O-METHYLTRANSFERASE INHIBITOR NITECAPONE IN THE RAT AND DOG
    WIKBERG, T
    TASKINEN, J
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (02) : 325 - 333
  • [4] Beneficial effect of nitecapone, an antioxidant and inhibitor of catechol-O-methyltransferase on renal dysfunction in diabetic rats
    Körner, A
    Eklöf, AC
    Jaremko, G
    Lal, M
    DiBona, G
    Aperia, A
    DIABETOLOGIA, 1999, 42 : A275 - A275
  • [5] DETERMINATION OF A CATECHOL-O-METHYLTRANSFERASE INHIBITOR, NITECAPONE, IN HUMAN PLASMA AND URINE BY LIQUID-CHROMATOGRAPHY
    WIKBERG, T
    TASKINEN, J
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (01) : 59 - 64
  • [6] INHIBITION OF HUMAN ERYTHROCYTE AND GASTRODUODENAL CATECHOL-O-METHYLTRANSFERASE ACTIVITY BY NITECAPONE
    SCHULTZ, E
    TARPILA, S
    BACKSTROM, AC
    GORDIN, A
    NISSINEN, E
    POHTO, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (06) : 577 - 580
  • [7] Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor
    Almeida, Luis
    Loureiro, Ana I.
    Vaz-da-Silva, Manuel
    Torrao, Leonel
    Maia, Joana
    Fernandes-Lopes, Carlos
    Falcao, Amilcar
    Igreja, Bruno
    Wright, Lyndon
    Soares-da-Silva, Patricio
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1097 - 1108
  • [8] Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in manA study using a stable isotope technique
    H. Heikkinen
    M. Saraheimo
    S. Antila
    P. Ottoila
    P.J. Pentikäinen
    European Journal of Clinical Pharmacology, 2001, 56 : 821 - 826
  • [9] EXERCISE HEMODYNAMICS AND CATECHOLAMINE METABOLISM AFTER CATECHOL-O-METHYLTRANSFERASE INHIBITION WITH NITECAPONE
    SUNDBERG, S
    SCHEININ, M
    OJALAKARLSSON, P
    KAAKKOLA, S
    AKKILA, J
    GORDIN, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) : 356 - 364
  • [10] EFFECT OF A NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR, NITECAPONE, ON THE METABOLISM OF L-DOPA IN HEALTHY-VOLUNTEERS
    KAAKKOLA, S
    GORDIN, A
    JARVINEN, M
    WIKBERG, T
    SCHULTZ, E
    NISSINEN, E
    PENTIKAINEN, PJ
    RITA, H
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (05) : 436 - 447
12345